We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is American Well (AMWL) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. American Well Corporation (AMWL - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
American Well Corporation is a member of the Medical sector. This group includes 926 individual stocks and currently holds a Zacks Sector Rank of #9. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. American Well Corporation is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for AMWL's full-year earnings has moved 36.6% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, AMWL has gained about 14.3% so far this year. Meanwhile, stocks in the Medical group have lost about 1% on average. This means that American Well Corporation is performing better than its sector in terms of year-to-date returns.
Catalyst Pharmaceutical (CPRX - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 4.2%.
In Catalyst Pharmaceutical's case, the consensus EPS estimate for the current year increased 13% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, American Well Corporation belongs to the Medical Info Systems industry, which includes 42 individual stocks and currently sits at #138 in the Zacks Industry Rank. On average, this group has lost an average of 18% so far this year, meaning that AMWL is performing better in terms of year-to-date returns.
Catalyst Pharmaceutical, however, belongs to the Medical - Drugs industry. Currently, this 143-stock industry is ranked #93. The industry has moved -2.7% so far this year.
Investors with an interest in Medical stocks should continue to track American Well Corporation and Catalyst Pharmaceutical. These stocks will be looking to continue their solid performance.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Is American Well (AMWL) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. American Well Corporation (AMWL - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
American Well Corporation is a member of the Medical sector. This group includes 926 individual stocks and currently holds a Zacks Sector Rank of #9. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. American Well Corporation is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for AMWL's full-year earnings has moved 36.6% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, AMWL has gained about 14.3% so far this year. Meanwhile, stocks in the Medical group have lost about 1% on average. This means that American Well Corporation is performing better than its sector in terms of year-to-date returns.
Catalyst Pharmaceutical (CPRX - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 4.2%.
In Catalyst Pharmaceutical's case, the consensus EPS estimate for the current year increased 13% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, American Well Corporation belongs to the Medical Info Systems industry, which includes 42 individual stocks and currently sits at #138 in the Zacks Industry Rank. On average, this group has lost an average of 18% so far this year, meaning that AMWL is performing better in terms of year-to-date returns.
Catalyst Pharmaceutical, however, belongs to the Medical - Drugs industry. Currently, this 143-stock industry is ranked #93. The industry has moved -2.7% so far this year.
Investors with an interest in Medical stocks should continue to track American Well Corporation and Catalyst Pharmaceutical. These stocks will be looking to continue their solid performance.